|  Help  |  About  |  Contact Us

Publication : Specificities of Gβγ subunits for the SNARE complex before and after stimulation of α(2a)-adrenergic receptors.

First Author  Yim YY Year  2021
Journal  Sci Signal Volume  14
Issue  714 Pages  eabc4970
PubMed ID  34932372 Mgi Jnum  J:347348
Mgi Id  MGI:7622152 Doi  10.1126/scisignal.abc4970
Citation  Yim YY, et al. (2021) Specificities of Gbetagamma subunits for the SNARE complex before and after stimulation of alpha(2a)-adrenergic receptors. Sci Signal 14(714):eabc4970
abstractText  Ligand binding to G protein-coupled receptors (GPCRs), such as the alpha(2a)-adrenergic receptor (alpha(2a)AR), results in the activation of heterotrimeric G proteins, which consist of functionally distinct Galpha subunits and Gbetagamma dimers. alpha(2a)AR-dependent inhibition of synaptic transmission regulates functions such as spontaneous locomotor activity, anesthetic sparing, and working memory enhancement and requires the soluble NSF attachment protein receptor (SNARE) complex, a Gbetagamma effector. To understand how the Gbetagamma-SNARE complex underlies the alpha(2a)AR-dependent inhibition of synaptic transmission, we examined the specificity of Gbetagamma subunits for the SNARE complex in adrenergic neurons, in which auto-alpha(2a)ARs respond to epinephrine released from these neurons, and nonadrenergic neurons, in which hetero-alpha(2a)ARs respond to epinephrine released from other neurons. We performed a quantitative, targeted multiple reaction monitoring proteomic analysis of Gbeta and Ggamma subunits bound to the SNARE complex in synaptosomes from mouse brains. In the absence of stimulation of auto-alpha(2a)ARs, Gbeta(1) and Ggamma(3) interacted with the SNARE complex. However, Gbeta(1), Gbeta(2), and Ggamma(3) were found in the complex when auto-alpha(2a)ARs were activated by epinephrine. Further understanding of the specific usage of distinct Gbetagamma subunits in vivo may provide insights into the homeostatic regulation of synaptic transmission and the mechanisms of dysfunction that occur in neurological diseases.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

13 Bio Entities

Trail: Publication

0 Expression